Randall Hyer
Overview
Explore the profile of Randall Hyer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Youhanna J, Tran V, Hyer R, Domnich A
Influenza Other Respir Viruses
. 2024 Apr;
18(4):e13286.
PMID: 38594827
Antigenic drift is a major driver of viral evolution and a primary reason why influenza vaccines must be reformulated annually. Mismatch between vaccine and circulating viral strains negatively affects vaccine...
2.
Rivera D, Kluetz P, Abdallah K, Agrawal S, Angus D, Califf R, et al.
Cancer J
. 2022 Mar;
28(2):151-156.
PMID: 35333502
Because of significant adaptations forced by the COVID-19 pandemic, resultant changes within health care delivery and clinical research introduced the potential for evaluation of novel evidence generation approaches in oncology....
3.
Janssen R, Bruxvoort K, Jacobsen S, Slezak J, David C, Hyer R, et al.
Vaccine
. 2021 Aug;
39(39):5666-5672.
PMID: 34404556
Background: In the absence of field efficacy studies, estimating the real-world effectiveness of vaccines may consider immunogenicity from randomized controlled clinical trials and real-world adherence. Combining seroprotection rates (SPRs) with...
4.
Bruxvoort K, Slezak J, Huang R, Ackerson B, Sy L, Qian L, et al.
JAMA Netw Open
. 2020 Nov;
3(11):e2027577.
PMID: 33252692
Importance: Receipt of hepatitis B virus vaccine is important to prevent infection. However, adherence to the hepatitis B vaccine series among adults at risk of infection has been low. Objective:...
5.
Hyer R, McGuire D, Xing B, Jackson S, Janssen R
Vaccine
. 2018 Apr;
36(19):2604-2611.
PMID: 29628151
Background: Hepatitis B virus infection remains an important global public health problem. Approved alum-adjuvanted vaccines are well tolerated but require three doses and have reduced immunogenicity in adults. A two-dose...
6.
Brabin L, Greenberg D, Hessel L, Hyer R, Ivanoff B, Van Damme P
Vaccine
. 2008 Jul;
26(33):4120-34.
PMID: 18617295
Based on the December 2006 Fondation Mérieux International Scientific Symposium, the current state of adolescent immunization is reviewed with a focus on the policy and programmatic issues that impact the...